YOLFTbeta
Indaptus Therapeutics Inc

Indaptus Therapeutics Inc

INDP · NASDAQ · Healthcare / Biotechnology

3.17USD+0.02 (+0.63%)

Price History

Full chart

Market Stats

Previous Close3.15
Open3.06
Day Range3.05 – 3.29
52-Week Range0.92 – 5.96
Volume113.19K
Market Cap512.98M
P/E (TTM)0.00
Forward P/E0.00
EPS-3.56
Dividend Yield0.00%
Beta1.17
50-Day Avg1.94
200-Day Avg2.26

About

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Junyi Dai
  • Employees5
  • HeadquartersThree Columbus Circle, New York, NY, United States, 10019, USA
  • Websitehttps://indaptusrx.com

Leadership

  • Mr. Junyi DaiCEO & Chairman · b. 1987
  • Mr. Yu DingChief Financial Officer · b. 1975

Financials

Income Statement

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue------------000000
Cost of Revenue302.32K305.53K367.33K340.68K555.43K602.85K584.82K745.90K701.00K829.00K859.00K854.00K8521.40K1.78K1.28K735-
Gross Profit-302.32K-305.53K-367.33K-340.68K-555.43K-602.85K-584.82K-745.90K-701.00K-829.00K-859.00K-854.00K-852-1.40K-1.78K-1.28K-735-
Operating Expense4.61M3.62M4.97M7.42M4.81M4.56M6.98M6.85M13.14M28.61M42.47M34.09M3.60M7.73M14.91M16.38M15.37M-
Operating Income-4.91M-3.93M-5.34M-7.76M-5.37M-5.17M-7.57M-7.60M-13.85M-29.44M-43.33M-34.95M-3.60M-7.73M-14.91M-16.38M-15.37M-19.83M
EBITDA-5.06M-3.64M-5.06M-7.24M-4.63M-4.49M-5.11M-6.43M-13.14M-28.61M-42.56M-46.09M-3.60M-7.71M-14.32M-15.42M-15.02M-20.85M
Net Income-5.36M-3.94M-5.42M-7.58M-5.18M-5.09M-5.69M-7.18M-13.36M-28.91M-43.54M-47.60M-3.58M-7.71M-14.32M-15.42M-15.02M-20.85M
R&D2.94M1.84M2.32M4.69M2.69M2.16M4.39M4.09M10.07M24.30M35.40M26.66M2.66M2.52M6.32M7.62M7.25M9.34M
Interest Expense--------16.00K17.00K23.00K15.00K15.11K17.72K588.11K---

Balance Sheet

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.16M3.29M12.54M9.06M7.77M13.68M12.49M37.28M24.72M64.55M61.51M21.28M1.78M40.58M28.06M14.92M7.34M9.31M
Total Liabilities4.26M1.72M1.03M1.29M918.23K4.39M3.02M1.65M2.02M5.75M7.96M9.74M2.02M4.68M3.43M2.85M3.39M6.16M
Total Equity-2.10M1.57M11.51M7.77M6.85M9.30M9.48M35.63M22.70M58.80M53.55M11.54M-237.70K35.90M24.63M12.08M3.94M3.15M
Cash667.20K1.65M4.74M3.30M611.88K3.40M5.80M23.78M16.44M53.39M39.25M9.29M1.64M39.13M9.63M13.36M5.79M8.51M
Total Debt2.94M----------1.34M169.33K169.33K80.49K175.05K84.16K-
Net Debt2.27M-1.65M-4.74M-3.30M-611.88K-3.40M-5.80M-23.78M-16.44M-53.39M-39.25M-7.95M-1.64M-38.96M-9.55M-13.19M-5.70M-8.51M

Cash Flow

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.78M-3.08M-4.31M-5.38M-4.50M-3.38M-4.75M-7.93M-12.01M-22.13M-39.08M-29.05M-3.32M-11.29M-13.08M-13.41M-12.32M-14.82M
Investing Cash Flow-188.70K-528.83K-5.23M1.17M-1.53M-3.12M2.72M-6.39M4.72M-4.75M-9.30M-3.21M447.75K447.75K-16.43M17.14M--
Financing Cash Flow3.93M4.55M12.56M2.98M3.38M9.28M4.83M31.94M-63.71M35.06M2.37M1.16M48.34M363.06K04.75M17.54M
Capital Expenditure203.22K528.83K474.77K2.31M206.40K1.49M75.76K1.39M482.00K5.00M9.60M921.00K8.21M3.85K172.56K504
Free Cash Flow-3.98M-3.61M-4.79M-7.69M-4.71M-4.87M-4.83M-9.32M-12.49M-27.13M-48.67M-29.97M-3.32M-11.29M-13.25M-13.41M-12.32M-14.82M
FCF to OCF105.38%117.18%111.01%142.91%104.58%144.00%101.59%117.55%104.01%122.60%124.56%103.17%100.00%100.03%101.32%100.00%100.00%100.00%

Earnings

Report DateDec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Jan 29, 2015Apr 27, 2015Jul 30, 2015Nov 5, 2015Mar 14, 2016Sep 1, 2016Dec 15, 2016Mar 27, 2017Apr 7, 2017Aug 10, 2017Nov 15, 2017Mar 9, 2018May 15, 2018Aug 15, 2018Nov 9, 2018Feb 27, 2019May 7, 2019Aug 9, 2019Nov 12, 2019Mar 13, 2020May 11, 2020Aug 5, 2020Nov 5, 2020Mar 16, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 21, 2022May 12, 2022Aug 8, 2022Nov 10, 2022Mar 17, 2023May 11, 2023Aug 14, 2023Nov 6, 2023Mar 13, 2024May 8, 2024Aug 12, 2024Nov 12, 2024Mar 13, 2025May 14, 2025Aug 13, 2025Nov 12, 2025Mar 17, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate------------10.80-12.80-29.60-0.30-0.30-29.60-24.80-27.20-22.00-22.67-26.08-24.96-24.16-29.40-24.16-17.40-12.00-6.13-4.27-3.47-3.40-3.48-2.56-15.40-16.80-0.83-12.04-14.28-14.56-0.59-16.24-14.56-0.54-15.96-15.40-13.16-0.47-5.04-9.24-4.17-4.36--
EPS Actual-10.26-12.60-10.59-13.67-19.07-13.57-12.93-13.85-0.46-28.22-12.82-12.80-23.20-30.40-4.300.00-25.60-37.60-32.00-30.40-32.80-27.20-22.40-29.60-25.60-24.00-25.60-14.40-6.40-4.00-3.80-2.12-3.84-5.53-22.68-6.16-0.41-12.88-11.76-12.32-0.51-10.92-13.16-0.48-12.60-13.16-8.96-0.37-8.96-9.09-2.98-9.19-0.02-
Surprise------------18.52%-81.25%-2.70%-1333.33%100.00%13.51%-51.61%-17.65%-38.18%-44.68%-4.29%10.26%-22.52%12.93%0.66%-47.13%-20.00%-4.40%6.32%-9.51%37.65%-10.34%-116.02%-47.27%63.33%50.60%-6.98%17.65%15.38%13.56%32.76%9.62%11.11%21.05%14.55%31.91%21.28%-77.78%1.62%28.54%-110.78%--
Timing--------After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours--Pre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hours--

Key Statistics & Ratios

Market Cap512.98M
Enterprise Value496.51M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book44.17
EPS-3.56
Book Value0.085
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-19.83M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-318.04%
Return on Assets-98.08%
Shares Outstanding133.24M
Shares Float23.36M
Beta1.17
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 10.00
  • Buy
    1

Ownership Breakdown

Institutions
0.30%
Insiders
82.45%
Retail / Other
17.25%

Top Institutional Holders

  • Geode Capital Management, LLC
    27.01K1.25%
  • Millennium Management LLC
    11.59K0.53%
  • Morgan Stanley - Brokerage Accounts
    2.70K0.12%
  • Tower Research Capital LLC
    1.89K0.09%
  • SBI Securities Co Ltd
    170.00%
  • CWM, LLC duplicate
    20.00%
  • Bank of America Corp
    00.00%
  • Citadel Advisors Llc
    00.00%
  • UBS Group AG
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    69.40K0.05%
  • Fidelity Extended Market Index
    11.47K0.01%
  • Morgan Stanley Pathway Sm-Md Cp Eq ETF
    11.00K0.01%
  • Fidelity Series Total Market Index
    3.93K0.00%
  • Fidelity Total Market Index
    4620.00%

Stock Splits

  • Jun 27, 20251:28
  • Jul 27, 20211:4
  • Oct 30, 20201:20